Media Alert: Douglas Holtz-Eakin and Fleet of Experts to Lead Affordable Care Act Discussion

Forum held on Wednesday, March 21, 2012 at The Hamilton; Livestream available

WHAT: Douglas Holtz-Eakin, Former Director of the Congressional Budget Office, and the American Action Forum are leading a discussion titled, "Affordable Care Act Turns 2 … Will it Turn 3?" In this discussion, Holtz-Eakin will answer big questions such as: What will be the major legal questions argued before the court? What are the economic implications of the court's ruling? How will the rulings impact Congress and the upcoming Presidential election? What will the court ultimately decide?

WHY: The National Law Journal cited Holtz-Eakin and the American Action Forum's Amicus Brief as one that is likely to influence the Supreme Court's ruling.  A fleet of economic and legal experts will be made available to the press, including:

  • Doug Holtz-Eakin, Former Director of the Congressional Budget Office and lead Amici on 3 Amicus Briefs in the Supreme Court Healthcare Case
  • Larry Lindsey, Former Chairman of the White House National Economic Council (NEC)
  • Art Laffer, Former Chief Economist of the Office of Management and Budget
  • Steven Engel, Former Supreme Court Clerk for Justice Kennedy, the key swing vote in the healthcare case
  • John Bash, Former Supreme Court Clerk for Justice Antonin Scalia, a potential swing vote in the healthcare case
  • Grace-Marie Turner, Served as a member of the Medicaid Commission

WHEN: Wednesday, March 21.
Breakfast begins at 9:30 a.m. ET
Program runs from 10:00 a.m.12:00 p.m. ET

WHERE: The Hamilton (14th St and F St NW). If you are unable to make it, the event can be viewed via livestream here: http://on.fb.me/tLdsFl 

Please RSVP to [email protected] or Call 202-370-3446

 

Event: The Affordable Care Act Turns 2...Will it Turn 3?
Evaluating the Supreme Court Challenge and the Potential Fall Out

On Monday, March 26, the Supreme Court is set to embark on a series of hearings that will analyze the legalities of the Affordable Care Act (ACA). What will be the major legal questions argued before the court? What are the economic implications of the court's ruling? How will the rulings impact Congress and the upcoming Presidential election? What will the court ultimately decide? These are just a few of the critical questions that will be answered by top scholars and legal experts next Wednesday, March 21, at an event hosted by the American Action Forum, a forward-looking policy institute examining the most pressing public policy issues of the day.

The Forum event will feature a discussion moderated by Politico reporter Alexander Burns that includes former Supreme Court clerks Steven Engel and John Bash. It will also feature American Action Forum President and former Director of the Congressional Budget Office, Douglas Holtz-Eakin, who filed three amici briefs focused on the economic implications of the legal challenge. The 11th Circuit Court of Appeals cited this economic analysis in its decision to overturn the individual mandate. Additionally, you will hear from Utah Governor Gary Herbert, a leading proponent of state-controlled healthcare and Karen Harned, Executive Director of the NFIB Small Business Legal Center.

These experts will be made available to the press.

Date: Wednesday, March 21
Time: 10am12pm, Breakfast served at 9:30am
Location: The Hamilton Live
600 14th Street, NW (Near Metro Center)
Washington DC 20005

Please RSVP to [email protected] or Call 202-370-3446

Press Contact:
Margaret McClain
202-944-1917
[email protected]

/PRNewswire-USNewswire -- March 20, 2012/

SOURCE American Action Forum

Suggested Articles

Microsoft is warning hospitals that sophisticated ransomware attacks are trying to exploit remote workers to gain access to their networks.

As more Americans lose their jobs amid the COVID-19 pandemic, the number of people without health insurance is also expected to rise. 

There could be imminent shortages of antimalarial drugs and antibiotics that are critical to providing care for COVID-19 patients.